Pennsylvania Becomes 20th US State To Enact Comprehensive Biomarker Legislation

Signed into law a bill requiring that state-regulated health insurance policies, including Medicaid, cover comprehensive biomarker testing.

Pennsylvania is the 20th state to enact comprehensive biomarker testing legislation, according to the American Cancer Society Cancer Action Network (ACS-CAN), the organization that penned model legislative language for these bills. Other states that have passed such legislation into law recently include Indiana and Texas. Biomarker legislation has been introduced in a handful of other states such as Massachusetts.

Source: https://www.precisionmedicineonline.com/precision-oncology/pennsylvania-becomes-20th-us-state-enact-comprehensive-biomarker-legislation